Featured Research

from universities, journals, and other organizations

Synergy between two types of de-worming drugs found promising in a lab test

Date:
April 2, 2010
Source:
University of California - San Diego
Summary:
Combining two types of anti-worm treatments that work in different ways could head off the development of drug resistance and save money by allowing lower doses of both drugs to be used.

A new combination drug treatment for parasitic intestinal roundworms shows promise in a test on a common laboratory species.

Several drugs currently in use or in development control parasitic worms in the same way. That concerns health workers In developing countries where reinfestations often require repeated treatments. If worms develop resistance to one drug, the other treatments would likely fail as well.

Raffi Aroian's research group at the University of California, San Diego recently demonstrated that a potential new drug, a protein crystal made by bacteria that works by a different mechanism, will rid laboratory animals of intestinal worms. This week, they report that combining these two types of anti-worm treatments could head off the development of drug resistance and save money by allowing lower doses of both drugs to be used. Their paper appears in the early online edition of the Proceedings of the National Academy of Sciences.

Worms that had become resistant to levamisole and similar drugs succumbed to lower doses of the crystal protein, the researchers found. "What was amazing was that we found the converse was also true. When the worms develop resistance to the crystal protein, they become more susceptible to the other class of drugs," said Aroian, a professor of biology at UC San Diego.

When they exposed worms to both classes of drugs simultaneously, lower doses of each were required to halt their reproduction or growth, or to kill adults. "You can actually reduce the amount of each drug that you use," Aroian said, which will reduce the chance of harmful side effects and lower costs. Combining drugs will also help to prevent drug resistance. "The worms would have to mutate two different things simultaneously to resist the combination therapy," he said.

Aroian's group tested the drugs on C. elegans, a common laboratory species. Because all known effective treatments for parasitic worms also kill C. elegans, this free-living soil nematode should be a good stand-in for the parasites, Aroian said. His lab has already begun to test the dual treatment on parasitic worms maintained in culture dishes and plans additional experiments with small animals infested with parasitic roundworms.

The crystal proteins, derived from a bacterium called Bt, are thought to be harmless to humans and other vertebrate animals. Although organic farmers have used them as pest controls for decades, Bt toxins will need to be tested for safety and effectiveness in clinical trials before they are approved for medical use.

The need for those trials is urgent, Aroian said. A recent study found that the drugs did a poor job of ridding school children living in Tanzania of intestinal parasites, evidence that the worms there are developing resistance to currently available treatments.

Although intestinal parasites damage health and mental functioning in ways that keep people poor, the world has made little investment in treating them. The George Institute for International Health, a non-profit organization based in Australia, estimates in a recent report that only $721 thousand dollars was spent worldwide in 2008 to develop treatments for intestinal parasites.

Yet with adequate funding, Aroian thinks the solutions are within reach. "We can do this," he said. "This is an enormous problem that we can solve."

Co-authors on the study include Yan Hu and Audrey Bellier in Aroian's group, and Edward Platzer at the University of California, Riverside. The National Institute of Allergy and Infectious Diseases funded the work.


Story Source:

The above story is based on materials provided by University of California - San Diego. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yan Hu, Edward G. Platzer, Audrey Bellier, and Raffi V. Aroian. Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility. PNAS, March 15, 2010 DOI: 10.1073/pnas.0912327107

Cite This Page:

University of California - San Diego. "Synergy between two types of de-worming drugs found promising in a lab test." ScienceDaily. ScienceDaily, 2 April 2010. <www.sciencedaily.com/releases/2010/03/100315162039.htm>.
University of California - San Diego. (2010, April 2). Synergy between two types of de-worming drugs found promising in a lab test. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2010/03/100315162039.htm
University of California - San Diego. "Synergy between two types of de-worming drugs found promising in a lab test." ScienceDaily. www.sciencedaily.com/releases/2010/03/100315162039.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mini Pacemaker Has No Wires

Mini Pacemaker Has No Wires

Ivanhoe (Aug. 27, 2014) Cardiac experts are testing a new experimental device designed to eliminate major surgery and still keep the heart on track. Video provided by Ivanhoe
Powered by NewsLook.com
After Cancer: Rebuilding Breasts With Fat

After Cancer: Rebuilding Breasts With Fat

Ivanhoe (Aug. 27, 2014) More than 269 million women are diagnosed with breast cancer each year. Many of them will need surgery and radiation, but there’s a new simple way to reconstruct tissue using a patient’s own fat. Video provided by Ivanhoe
Powered by NewsLook.com
Blood Clots in Kids

Blood Clots in Kids

Ivanhoe (Aug. 27, 2014) Every year, up to 200,000 Americans die from a blood clot that travels to their lungs. You’ve heard about clots in adults, but new research shows kids can get them too. Video provided by Ivanhoe
Powered by NewsLook.com
Radio Waves Knock out Knee Pain

Radio Waves Knock out Knee Pain

Ivanhoe (Aug. 27, 2014) Doctors have used radio frequency ablation or RFA to reduce neck and back pain for years. But now, that same technique is providing longer-term relief for patients with severe knee pain. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins